Further, GDE2 deficits are evident in human neural cell models of ALS, which display erroneous Wnt activation that, when inhibited, increases mRNA levels of genes regulated by TDP-43. The gene discussed is GDPD5; the disease is amyotrophic lateral sclerosis.